HPHARMA
Board
1 director, no change since 2023Director (not named in the articles), permanent representative
since 01-05-2020
term without a fixed end
earlier manager, until 09-10-2023
listed in the 2025 annual accounts, filed on 10-06-2026
Permanent representatives 1
Mandates through the years
3 names, the dashed line is todayDirector (not named in the articles)
Director
Manager (not named in the articles)
BoardEarliermandate already running before its first mentionend not dated
Mandates as a list
-
- Director, from 01-05-2020 to 09-10-2023
- Director (not named in the articles), since before 09-10-2023
-
- Director, until 22-07-2020
-
- Manager (not named in the articles), appointed by deed of 04-09-2017, no longer listed in the 2025 annual accounts
Control
Shareholder
This company
HPHARMA
Equity €264,577
Profit €18,505 in 2025
Capital
- Contribution
- €46,500
- Shares
- 465
- Contribution per share
- €100
- Equity per share
- €569 in 2025
- Source
- 2025 annual accounts
Articles of association
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 04-09-2017 (in French)
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- “Lorsque la loi l'exige et dans les limites qu'elle prévoit, le contrôle de la société est assuré par un ou plusieurs commissaires, nommés…”deed of 09-10-2023 (in French)
Shareholders
Stated in the deed
deed of 09-10-2023 ↗
- all shares
At incorporation
deed of 04-09-2017 ↗
- 465 shares (100%) · €46,500 in cash
Capital transactions
Capital over time
- 09-10-2023 Converted to unavailable equity
- 04-09-2017 Incorporation · €46,500 · 465 shares